Literature DB >> 6110604

Acute effects of alloxan- and streptozotocin-induced insulin deficiency on somatostatin and glucagon secretion by the perfused isolated rat pancreatico-duodenal preparation.

Y Goto, M Berelowitz, L A Frohman.   

Abstract

The secretion of somatostatin and glucagon by the perfused rat pancreatico-duodenal preparation was examined in situ under control conditions and after the induction of acute insulin deficiency by alloxan or streptozotocin. A 10 min 0.625 mmol/l alloxan perfusion resulted in an immediate and transient increase in basal insulin and glucagon release and a slightly delayed and persistent increase in basal somatostatin secretion. The insulin responses to 16.7 mmol/l glucose, 1 mmol/l theophylline, and 19 mmol/l arginine alone or in combination were virtually eliminated by alloxan treatment. Somatostatin secretion in response to the stimuli was completely inhibited or markedly attenuated. The glucagon-suppressive effect of glucose was unaltered by alloxan and the stimulatory effect of arginine was enhanced. Addition of 1 microgram/ml porcine insulin to the perfusion medium did not modify the alterations in somatostatin and glucagon responses to arginine. Streptozotocin treatment 90 min prior to the onset of perfusion resulted in changes in somatostatin, glucagon, and insulin responses to glucose and arginine similar to those of alloxan. The present results are consistent with an effect of alloxan and streptozotocin on the D cell similar to that on the B cells, namely, interference with a glucose-mediated effect on hormone secretion.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6110604     DOI: 10.1007/bf00253820

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  23 in total

1.  Letter: Ultrastructural immunocytochemical localization of somatostatin in rat pancreatic monolayer culture.

Authors:  C Rufener; M P DuBois; L Orci
Journal:  J Histochem Cytochem       Date:  1975-11       Impact factor: 2.479

2.  Immunoreactive somatostatin levels in plasma of normal and alloxan diabetic dogs.

Authors:  V Schusdziarra; R E Dobbs; V Harris; R H Unger
Journal:  FEBS Lett       Date:  1977-09-01       Impact factor: 4.124

3.  Somatostatin: hypothalamic inhibitor of the endocrine pancreas.

Authors:  D J Koerker; W Ruch; E Chideckel; J Palmer; C J Goodner; J Ensinck; C C Gale
Journal:  Science       Date:  1974-04-26       Impact factor: 47.728

4.  Increased somatostatin release from pancreases of alloxan diabetic rats perfused in vitro.

Authors:  M Hara; G Patton; J Gerich
Journal:  Life Sci       Date:  1979-02-12       Impact factor: 5.037

5.  Modulation by alloxan of glucagon and insulin secretion in the isolated perfused rat pancreas.

Authors:  Y Goto; Y Seino; T Taminato; Y Inoue; S Kadowaki; K Mori; H Imura
Journal:  Endocrinology       Date:  1978-05       Impact factor: 4.736

6.  Glucose and 3-O-methylglucose protection against alloxan poisoning of pancreatic alpha and beta cells.

Authors:  A S Pagliara; S N Stillings; W S Zawalich; A D Williams; F M Matchinsky
Journal:  Diabetes       Date:  1977-10       Impact factor: 9.461

7.  Theophylline: potentiation of arginine-induced somatostatin release from the isolated rat pancreas.

Authors:  Y Goto; Y Seino; T Taminato; S Kadowaki; T Chiba; S Note; H Imura
Journal:  Diabetes       Date:  1979-05       Impact factor: 9.461

8.  Streptozotocin diabetes: a glucoreceptor dysfunction affecting D cells as well as B and A cells.

Authors:  K Hermansen; H Orskov; S E Christensen
Journal:  Diabetologia       Date:  1979-12       Impact factor: 10.122

9.  The role of sodium in somatostatin secretion: evidence for the involvement of Na+ channels in the release mechanism.

Authors:  K Hermansen
Journal:  Endocrinology       Date:  1980-06       Impact factor: 4.736

10.  Increased somatostatin content of islets from streptozotocin-diabetic rats.

Authors:  Y C Patel; G C Weir
Journal:  Clin Endocrinol (Oxf)       Date:  1976-03       Impact factor: 3.478

View more
  5 in total

1.  Role of glucose and insulin in the dynamic regulation of glucagon release by the perfused rat pancreas.

Authors:  V Leclercq-Meyer; J Marchand; W J Malaisse
Journal:  Diabetologia       Date:  1983-03       Impact factor: 10.122

2.  Sulfonylurea-induced inhibition of glucagon secretion from the perfused rat pancreas: evidence for a direct, non-paracrine effect.

Authors:  C G Ostenson; A Nylén; V Grill; M Gutniak; S Efendić
Journal:  Diabetologia       Date:  1986-12       Impact factor: 10.122

3.  Modulation by glucose and D-glyceraldehyde of glucagon and insulin secretion in the isolated perfused streptozotocin-treated rat pancreas.

Authors:  Y Goto; Y Seino; S Note; H Imura
Journal:  Acta Diabetol Lat       Date:  1982 Jan-Mar

4.  Pentamidine, a new diabetogenic drug in laboratory rodents.

Authors:  P Saï; D Boillot; C Boitard; M Debray-Sachs; G Reach; R Assan
Journal:  Diabetologia       Date:  1983-11       Impact factor: 10.122

5.  Loss of a priming effect of glucose on A and D cell secretion in perfused pancreases from alloxan-diabetic rats: role of insulin and alloxan.

Authors:  V Grill; S Efendić
Journal:  Diabetologia       Date:  1983-01       Impact factor: 10.122

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.